Cresca Capital is a specialized advisory firm guiding biotech companies through transformative mergers, acquisitions, and strategic financings.
Get in TouchCresca Capital concentrates its advisory practice across high-impact therapeutic categories at the forefront of biomedical innovation.
We provide end-to-end transaction advisory across buy-side and sell-side mandates, with deep expertise in life sciences deal structuring.
Systematic identification and prioritization of targets or acquirers aligned with strategic objectives. We map the competitive landscape and surface the right counterparties before opportunities reach the open market.
Comprehensive scientific, commercial, and financial diligence — whether assessing a target's pipeline and IP or preparing a seller's data room to withstand rigorous buyer scrutiny.
End-to-end process management from term sheet through closing — including valuation, negotiation strategy, deal structuring, and coordination with legal, regulatory, and financial counterparties.
Advisory on complex or time-sensitive transactions — asset carve-outs, licensing partnerships, spin-outs, royalty monetizations, and restructurings requiring creative structuring and rapid execution.
Strategic and structural readiness advisory for companies approaching a public offering — including equity story development, investor positioning, and coordination with underwriters and counsel ahead of listing.
Our scientific advisory board brings deep domain expertise across neuroscience, oncology, and translational medicine to inform every transaction.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.
BA Economics-Mathematics · Columbia College, Columbia University
Heloise advises on M&A and fundraising as a Registered Representative with Cresca Capital, a life sciences-focused advisory firm (neuro/CNS, pain, women's health, and longevity), and as a Partner at Luminarc Labs, where she works with investors and startups on high-impact projects.
Prior to these roles, she sourced and diligenced acquisition and investment opportunities at Saltwater Capital (founded by Uber's first CEO, Ryan Graves), Thrasio (ecommerce unicorn), and Secocha Ventures (early-stage VC).
Heloise holds a Bachelor's degree in Economics-Mathematics from Columbia College, Columbia University.
We welcome inquiries from founders, management teams, and investors navigating transactions in the life sciences sector.
heloise@crescacap.comResponse within one business day
Whether you're exploring a potential acquisition, preparing for a sale process, or evaluating strategic alternatives, Cresca Capital can provide the expertise and relationships to help you execute with confidence.